Rhinogen BPE Atrophic Rhinitis Vaccine
رينوجين بي بي إي لقاح التهاب الأنف الضموري في الخنازير
Rhinogen BPE is an adjuvanted bacterin-toxoid for the vaccination of healthy swine against atrophic rhinitis caused by Bordetella bronchiseptica or the dermonecrotic toxin of Pasteurella multocida Type D, and erysipelas caused by Erysipelothrix rhusiopathiae.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
Vials of 50 doses (100 mL) and 125 doses (250 mL)
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Swine | 2 mL administered intramuscularly | Intramuscular (IM) | Sows/gilts: 2 doses at 4 and 2 weeks pre-farrowing; Piglets: 2 doses at 7-10 days and 3-4 weeks |
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Swine | 21 |
Indications
-
Vaccination of healthy swine as an aid in preventing atrophic rhinitis and erysipelas.
Contraindications
-
Do not vaccinate clinically ill or malnourished animals.
Precautions
-
Contains thimerosal as a preservative. Epinephrine should be available in case of anaphylactoid reaction.
Side Effects
-
Transient local swelling or mild stiffness following injection.
Images
Documents
-
Download
Rhinogen BPE Atrophic Rhinitis Vaccine Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
No data available
Information has not been added yet.
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.